Evidence map›Paper›PMID 24790821›Full record

ArticleSpringerPlus2014

Patient perceptions and expectations regarding imaging for metastatic disease in early stage breast cancer.

Demetrios Simos, Brian Hutton, Ian D Graham, Angel Arnaout, Jean-Michel Caudrelier, Sasha Mazzarello, Mark Clemons

Abstract read
In one paragraph

Article in SpringerPlus, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015
    Article
  16. Third-party online surveys-science, selling, or sugging?Current oncology (Toronto, Ont.) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Demetrios SimosDivision of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa, Canada ; Ottawa Hospital Research Institute, Ottawa, Canada ; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, 501 Smyth Road, Box 900, Ottawa, K1H8L6 Canada.
Brian HuttonDepartment of Epidemiology and Community Medicine, Centre for Practice Changing Research, University of Ottawa, Ottawa, Canada.
Ian D GrahamDepartment of Epidemiology and Community Medicine, Centre for Practice Changing Research, University of Ottawa, Ottawa, Canada.
Angel ArnaoutDepartment of Surgery, University of Ottawa, Ottawa, Canada.
Jean-Michel CaudrelierDivision of Radiation Oncology and Department of Radiology, University of Ottawa, Ottawa, Canada.
Sasha MazzarelloOttawa Hospital Research Institute, Ottawa, Canada.
Mark ClemonsDivision of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa, Canada ; Ottawa Hospital Research Institute, Ottawa, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe probability of detecting radiologically evident metastatic disease in asymptomatic women with newly diagnosed operable breast cancer is low. Despite the recommendations of most practice guidelines imaging is still frequently performed. Relatively little is known about what patients believe is important when it comes to radiologic staging.

methodsPatients with early stage breast cancer who had completed their definitive breast surgery were surveyed about their personal experiences, perceptions, and expectations on the issue of perioperative imaging for distant metastatic disease.

resultsOver a 3 month period, 245 women with primary operable breast cancer completed the questionnaire (87.0% response rate) and 80.8% indicated having had at least one imaging test for distant metastatic disease. These were either of the thorax (72.2%), abdomen (55.9%) or skeleton (65.3%) with a total of 701 imaging tests (average of 3.5 tests per patient imaged) performed. Overall, 57.1% indicated that they would want imaging done if the chance of detecting metastases was ≤10%. Although 80.0% of patients indicated that, "doing whatever their doctor recommended" was important to them, 70.4% also noted that they would be uncomfortable if their physician did not order imaging, even if this was in keeping with practice guidelines.

conclusionsMost patients with early stage breast cancer recall having imaging tests for distant metastases. Given the choice, most would prefer having imaging performed, even if this is not in line with current guidelines. If patient expectations are, in part, driving excessive imaging, new strategies addressing this are required.

Indexed as

GuidelinesImagingMetastasesOperable breast cancerPatient perceptions

Identifiers

PMID24790821
PMCPMC4000356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.